Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

Dazukibart, a type I interferon inhibitor, reduced dermatomyositis disease severity while maintaining a well-tolerated safety profile among patients, according to a study. “Dermatomyositis is a ...

Military Outreach and Veterans Engagement (MOVE), launched in 2019 by the North Carolina Biotechnology Center, has joined the U.S. Department of Defense’s SkillBridge initiative. SkillBridge provides ...

Military Outreach and Veterans Engagement (MOVE), launched in 2019 by the North Carolina Biotechnology Center, has joined the U.S. Department of Defense’s SkillBridge initiative. SkillBridge provides ...

Pfizer Inc. got a reprieve — at least for now — in its battle with activist investor Starboard Value LP, according to people ...

Based in the United Kingdom, Haleon makes consumer health care products, including Advil, Centrum Multivitamin and Aquafresh ...

Following a tough opening salvo from Starboard Value last fall, Pfizer is getting a chance to catch its breath in the ...

Pfizer Inc (NYSE:PFE) shares are trading higher Monday. Some of the optimism may be surrounding activist Starboard Value's ...

Pfizer, on behalf of its subsidiary Biohaven Pharmaceutical Holding Company, agreed to pay $59,746,277 to resolve allegations that prior to Pfizer's acquisition, Biohaven paid kickbacks to physicians ...

CooperVision has appointed Steven Robins as president, Americas, effective immediately. Robins is a three-decade healthcare ...

Over the years, the U.S. Department of Justice (DOJ) has taken a host of drugmakers to task over alleged kickback payments ...